James R. Jobe's Insider Trades & SAST Disclosures

James R. Jobe's most recent trade in National Health Investors, Inc. was a trade of 10,000 Stock Option (Right to Buy) 2025 done . Disclosure was reported to the exchange on March 3, 2025.

Share

Note

This is a custom search result for pattern James R. Jobe.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Show

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
National Health Investors,...	James R. Jobe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2025	10,000	10,000	-		-	Stock Option (Right to Buy) 2025
National Health Investors,...	James R. Jobe	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.63 per share.	23 Aug 2024	31,289	28,690 (0%)	0%	78.6	2,460,254	Common Stock - Jointly held with spouse
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share.	23 Aug 2024	25,000	39,979 (0%)	0%	53.4	1,335,250	Common Stock - Jointly held with spouse
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Aug 2024	25,000	0	-		-	Stock Option (Right to buy) 2022
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.73 per share.	23 Aug 2024	10,000	49,979 (0%)	0%	54.7	547,300	Common Stock - Jointly held with spouse
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share.	23 Aug 2024	10,000	59,979 (0%)	0%	57.8	577,600	Common Stock - Jointly held with spouse
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Aug 2024	10,000	0	-		-	Stock Option (Right to Buy) 2023
National Health Investors,...	James R. Jobe	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Aug 2024	10,000	0	-		-	Stock Option (Right to Buy) 2024
National Health Investors,...	R. Jobe James	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Feb 2024	10,000	10,000	-		-	Stock Option (Right to Buy) 2024
National Health Investors,...	James R. Jobe	Director	Purchase of securities on an exchange or from another person at price $ 51.40 per share.	30 Aug 2023	1,000	14,979 (0%)	0%	51.4	51,398	Common Stock - Jointly held with spouse
National Health Investors,...	James R. Jobe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2023	10,000	10,000	-		-	Stock Option (Right to Buy) 2023
National Health Investors,...	James R. Jobe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2022	25,000	25,000	-		-	Stock Option (Right to buy) 2022
National Health Investors,...	James R. Jobe	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2021	25,000	25,000	-		-	Stock Options (Right to Buy) 2-25-2021

Showing 1 to 13 of 13 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades